Prostate Cancer
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
January 5, 2024
Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective.
January 5, 2024
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
January 5, 2024